These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of congeners of amphetamine on the human heart. Neumann J; Dhein S; Kirchhefer U; Hofmann B; Gergs U Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4615-4642. PubMed ID: 38340182 [TBL] [Abstract][Full Text] [Related]
4. Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder. Aldosary F; Norris S; Tremblay P; James JS; Ritchie JC; Blier P Int J Neuropsychopharmacol; 2022 Apr; 25(4):283-292. PubMed ID: 34958348 [TBL] [Abstract][Full Text] [Related]
5. In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions. Flanagan S; Bartizal K; Minassian SL; Fang E; Prokocimer P Antimicrob Agents Chemother; 2013 Jul; 57(7):3060-6. PubMed ID: 23612197 [TBL] [Abstract][Full Text] [Related]
15. Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats. Burkard W; d'Agostini F; Kettler R; Da Prada M Psychopharmacology (Berl); 1992; 106 Suppl():S35-6. PubMed ID: 1546137 [TBL] [Abstract][Full Text] [Related]
16. Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition. Cattaneo C; Caccia C; Marzo A; Maj R; Fariello RG Clin Neuropharmacol; 2003; 26(4):213-7. PubMed ID: 12897643 [TBL] [Abstract][Full Text] [Related]